FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Meitheal Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Meitheal Pharmaceuticals' supplemental application for octreotide acetate. This approval authorizes a generic octreotide acetate product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Carcinoid Syndrome
• Esophageal Variceal Bleeding
• Vipoma

Drugs mentioned

• OCTREOTIDE ACETATE (octreotide acetate)

Snippet

SUPPL AP for OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)